What is Aplimod used for?

Aplimod is being studied as a potential treatment for Crohn's disease, COVID-19, and common variable immunodeficiency.

Is Aplimod FDA approved?

No, Aplimod is currently a research compound in clinical trial phases and is not yet approved for medical use.

What stage of testing is Aplimod in?

Aplimod is currently in Phase 1 and Phase 2 clinical trials.

Can Aplimod treat Crohn's disease?

Researchers are currently investigating if Aplimod can help treat Crohn's disease.

Is Aplimod being studied for COVID-19?

Yes, clinical research is looking into the use of Aplimod for COVID-19.

What is common variable immunodeficiency?

It is a condition being studied in relation to Aplimod during early clinical testing.

apilimod | CAS 541550-19-0 | HSKAZIJJKRAJAV

Loading compound...

Small molecule research compound

Aplimod is a small molecule drug currently being studied in clinical trials. It is being researched for its potential use in treating Crohn's disease, COVID-19, and common variable immunodeficiency.

How it worksThe specific way Aplimod works in the body is not yet fully detailed in the available clinical data.

Used for

Crohn's diseaseCOVID-19common variable immunodeficiency

Conditions

Crohn's diseaseCOVID-19common variable immunodeficiency

Class

Small moleculeSmall molecule research compound

How to take

Aplimod is currently in the research and development phase (Phase 1 and 2) and is not yet an approved medication for general use.

Talk to your doctor

Questions to ask

·Is Aplimod part of any clinical trials I can join?
·How is Aplimod being tested for Crohn's disease?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)